Rezurock (belumosudil) is a medication used to treat chronic graft-versus-host disease (GVHD) in adults after previous treatments have failed. Chronic GVHD occurs when the immune system attacks organs in the recipient’s body after a transplant. Rezurock works by inhibiting the protein ROCK2, reducing inflammation in the affected organs.